Developing Novel Clinical Outcome Assessments (COAs) for Psychiatric Illnesses
Publication
, Conference
Brady, L; Eremenc, S; Keefe, R; Trivedi, M; Sand, M; Koblan, K; Stafford, E; Streiff, R; Lisanby, S
Published in: NEUROPSYCHOPHARMACOLOGY
2022
Duke Scholars
Published In
NEUROPSYCHOPHARMACOLOGY
EISSN
1740-634X
ISSN
0893-133X
Publication Date
2022
Volume
47
Start / End Page
2 / 3
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Brady, L., Eremenc, S., Keefe, R., Trivedi, M., Sand, M., Koblan, K., … Lisanby, S. (2022). Developing Novel Clinical Outcome Assessments (COAs) for Psychiatric Illnesses. In NEUROPSYCHOPHARMACOLOGY (Vol. 47, pp. 2–3).
Brady, Linda, Sonya Eremenc, Richard Keefe, Madhukar Trivedi, Michael Sand, Kenneth Koblan, Elizabeth Stafford, Rachel Streiff, and Sarah Lisanby. “Developing Novel Clinical Outcome Assessments (COAs) for Psychiatric Illnesses.” In NEUROPSYCHOPHARMACOLOGY, 47:2–3, 2022.
Brady L, Eremenc S, Keefe R, Trivedi M, Sand M, Koblan K, et al. Developing Novel Clinical Outcome Assessments (COAs) for Psychiatric Illnesses. In: NEUROPSYCHOPHARMACOLOGY. 2022. p. 2–3.
Brady, Linda, et al. “Developing Novel Clinical Outcome Assessments (COAs) for Psychiatric Illnesses.” NEUROPSYCHOPHARMACOLOGY, vol. 47, 2022, pp. 2–3.
Brady L, Eremenc S, Keefe R, Trivedi M, Sand M, Koblan K, Stafford E, Streiff R, Lisanby S. Developing Novel Clinical Outcome Assessments (COAs) for Psychiatric Illnesses. NEUROPSYCHOPHARMACOLOGY. 2022. p. 2–3.
Published In
NEUROPSYCHOPHARMACOLOGY
EISSN
1740-634X
ISSN
0893-133X
Publication Date
2022
Volume
47
Start / End Page
2 / 3
Related Subject Headings
- Psychiatry
- 5202 Biological psychology
- 3209 Neurosciences
- 17 Psychology and Cognitive Sciences
- 11 Medical and Health Sciences